Scientific background of the scientific team of Imavita (Bibliography / Publications / Scientific Communications)

Imavita publications / Preclinical efficacy CRO

Poitevin S, Cussac D, Leroyer AS, Albinet V, Sarlon-Bartoli G, Guillet B, Hubert L, Andrieu-Abadie N, Couderc B, Parini A, Dignat-George F, Sabatier F, Sphingosine kinase 1 expressed by endothelial colony-forming cells has a critical role in their revascularization activity. Cardiovasc Res. 2014 Jul 1;103(1):121-30  (PubMed link).

Albinet V, Bats ML, Huwiler A, Rochaix P, Chevreau C, Ségui B, Levade T, Andrieu-Abadie N. Dual role of sphingosine kinase-1 in promoting the differentiation of dermal fibroblasts and the dissemination of melanoma cells. Oncogene. 2013 Jul 29 (PubMed link).

Albinet V, Bats ML, Bedia C, Sabourdy F, Garcia V, Ségui B, Andrieu-Abadie N, Hornemann T, Levade T. Genetic disorders of simple sphingolipid metabolism. Sphingolipids: Basic Science and Drug Development, Handbook of Experimental Pharmacology Volume 215, 2013, pp 127-152 (PubMed link).

Sorli SC, Colié S, Albinet V, Bedia C, Carpentier S, Ségui B, Guilbaud N, Levade T, Andrieu-Abadie N. Non-lysosomal beta-glucosidase GBA2 as a novel source of glucosylceramide catabolism involved in the regulation of melanoma growth. FASEB J. 2013 Feb;27(2):489-98 (PubMed link).

Lacoste E, Dual energy computed tomography imaging of atherosclerosis in an induced focal aortic inflammation rabbit model, Proceedings European Atherosclerosis Society 2012 / Milan, Italy.

Lacoste E, Lipidomics for the research of surrogate biomarkers in milk from cows with sub-clinical mastitis: a pilot study, Proceedings European Association of Veterinary Pharmacology and Toxicology 2012 / Noordwijkerhout, The Netherlands.

Lacoste E, Dual energy computed tomography imaging of atherosclerosis in a diet induced atheroma rabbit model, Proceedings European Atherosclerosis Society 2011 / Goteborg, Sweden.

Kovalchin J, Krieger J, Collins K, Genova M, Augustyniak M, Masci A, Avril T, Gandon G, Patat A, Fauchoux N, Toutin C, Lacoste E, Patel U, Mascioli E, Zanelli E, Safety, pharmacokinetic, and pharmacodynamic evaluations of PI-2301, a potent immunomodulator, in a first-in-human, single-ascending-dose study in healthy volunteers. J Clin Pharmacol. 2011 May;51(5):649-60 (PubMed link).

Albinet V, Bedia C, Huwiler A, Levade T, Andrieu-Abadie N, Role of sphingolipids in melanoma-stroma interactions, Bulletin du Cancer, Oct 2010, 97(4), S18-S18.

Colié S, Van Veldhoven PP, Kedjouar B, Bedia C, Albinet V, Sorli SC, Garcia V, Djavaheri-Mergny M, Bauvy C, Codogno P, Levade T, Andrieu-Abadie N. Disruption of sphingosine 1-phosphate lyase confers resistance to chemotherapy and promotes oncogenesis through Bcl-2/Bcl-xL upregulation. Cancer Res. 2009 Dec 15;69(24):9346-53 (PubMed link).

Autefage H, Albinet V, Garcia V, Berges H, Nicolau ML, Therville N, Altié MF, Caillaud C, Levade T, Andrieu-Abadie N. Lysosomal serine protease CLN2 regulates tumor necrosis factor-alpha-mediated apoptosis in a Bid-dependent manner. J Biol Chem. 2009 Apr 24;284(17):11507-16 (PubMed link).

DeLay RL, Lacoste E, Mezzasalma T, Blond-Riou F, Pharmacokinetics of metaflumizone and amitraz in the plasma and hair of dogs following topical application, Vet. Parasitol., 2007, 150 (3), 251-7 (PubMed link).

DeLay RL, Lacoste E, Delprat S, Blond-Riou F, Pharmacokinetics of metaflumizone and amitraz in the plasma and hair of cats following topical application, Vet. Parasitol., 2007, 150 (3), 258-62 (PubMed link)

Alvinerie M, Lacoste E, Sutra JF, Chartier C.Some pharmacokinetic parameters of eprinomectin in goats following pour-on administration, Vet Res Commun. 1999 Nov;23(7):449-55 (PubMed link).

Gravityscan Badge